Hays Advisory’s Usana Health Sciences USNA Stock Holding History

Hays Advisory’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-24,536	Closed	-$2.96M	–	57
2018 Q3	$2.96M	Sell	24,536 -889	-3%	-$110K	1.88%	15
2018 Q2	$2.93M	Sell	25,425 -2,001	-7%	-$219K	1.62%	15
2018 Q1	$2.36M	Sell	27,426 -13,591	-33%	-$1.05M	1.14%	26
2017 Q4	$3.04M	Sell	41,017 -17,410	-30%	-$1.16M	1.08%	28
2017 Q3	$3.37M	Sell	58,427 -5,363	-8%	-$317K	0.97%	31
2017 Q2	$4.09M	Sell	63,790 -7,971	-11%	-$491K	1%	29
2017 Q1	$4.13M	Sell	71,761 -7,749	-10%	-$463K	0.97%	30
2016 Q4	$4.87M	Sell	79,510 -22,934	-22%	-$1.49M	1.09%	24
2016 Q3	$7.09M	Sell	102,444 -10,934	-10%	-$721K	1.18%	22
2016 Q2	$6.32M	Sell	113,378 -18,608	-14%	-$1.12M	0.98%	26
2016 Q1	$8.01M	Sell	131,986 -17,156	-12%	-$1.01M	1.13%	21
2015 Q4	$9.53M	Sell	149,142 -13,318	-8%	-$864K	1.62%	17
2015 Q3	$10.9M	Sell	162,460 -46,138	-22%	-$3.26M	1.65%	17
2015 Q2	$14.3M	Sell	208,598 -15,754	-7%	-$1,000K	2.07%	12
2015 Q1	$12.5M	Buy	+224,352	New	+$11.5M	1.61%	24

Other funds holding USNA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hays Advisory's USNA Position: Q4 2018 in Review

Hays Advisory sold out of Usana Health Sciences (USNA) in Q4 2018, closing a stake of 24,536 shares — an estimated $2.96M sold.

Hays Advisory first reported a position in USNA in Q1 2015 and held it in 15 quarters. The position peaked at $14.3M in Q2 2015. 190 funds tracked by Wall St. Rank hold USNA as of Q4 2018.

Hays Advisory reported no remaining Usana Health Sciences position as of Q4 2018 after selling out during the quarter.
Hays Advisory sold 24,536 Usana Health Sciences shares in Q4 2018, an estimated $2.96M.
Hays Advisory first reported a position in Usana Health Sciences in Q1 2015 and held it in 15 quarters.
Hays Advisory's Usana Health Sciences position peaked at $14.3M in Q2 2015.
190 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2018.

Based on Hays Advisory's 13F filing for Q4 2018.